Does the Degree of Hepatocellular Carcinoma Tumor Necrosis following Transarterial Chemoembolization Impact Patient Survival?

Figure 3

Unadjusted post-TACE survival as a function of mRECIST dichotomized into responders (complete and partial response) and nonresponders (stable and progressive disease).